ASX:DLX DuluxGroup (DLX) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free DLX Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield3.21%Price TargetN/A Stock AnalysisStock Analysis Get DuluxGroup alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About DuluxGroup Stock (ASX:DLX)DuluxGroup Limited manufactures, markets, sells, and distributes paints, coatings, adhesives, and garden care and other building products in Australia, New Zealand, Papua New Guinea, South East Asia, China, and the United Kingdom. The company's Dulux ANZ segment offers decorative paints; and woodcare, texture, protective, powder, and industrial coatings for consumer and professional trade markets. Its Selleys & Parchem ANZ segment provides adhesives, sealants, and other household repair and maintenance products for the consumer and professional trade markets; and construction chemicals, decorative concrete solutions, and related equipment. The company's B&D Group segment offers garage doors and electronic openers for residential, commercial, and industrial use. Its Lincoln Sentry segment distributes cabinet and architectural hardware to the cabinet making industry, as well as window, door, and glazing industries. The company's Other Businesses segment offers garden care and home improvement products, specialty coatings and adhesives, coatings, and decorative paints. DuluxGroup Limited was founded in 1918 is headquartered in Clayton, Australia.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> DLX Stock News HeadlinesDecember 1, 2023 | seekingalpha.comDLX Dividend Yield GradeOctober 18, 2023 | investing.comDLX Historical DataApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.January 12, 2023 | msn.comBell Releases Carlin Dunne Limited Edition Race Star DLX Flex HelmetOctober 15, 2022 | fool.comDeluxe (NYSE: DLX)September 20, 2022 | finance.yahoo.comDeluxe Corporation (DLX)September 6, 2022 | fool.com.au5.42% Dividend yield: Why the DuluxGroup Limited share price is a buySeptember 5, 2022 | fool.com.au5 income shares I’d love to buy with $5,000 todayApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.July 4, 2022 | fool.com.auUp 10% in 2017, is the DuluxGroup Limited share price still attractive?June 14, 2022 | fool.com.au3 shares to beat buying investment propertiesSee More Headlines Receive DLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DuluxGroup and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/13/2018Today4/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorIndustrials Industry General Building Materials Sub-IndustryN/A Current SymbolASX:DLX CUSIPN/A CIKN/A Webwww.duluxgroup.com.au Phone+61-3-92635678FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares389,249,984Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Patrick William Houlihan (Age 52)CEO, MD & Exec. Director Mr. Stuart Ronald Boxer B.E.BEng (Hons), CFO & Exec. DirectorMr. Patrick JonesChief Operating Officer of Dulux Paints & CoatingsMr. Brad Hordern BEng (Hons)Exec. Gen. Mang. of Supply ChainMr. Martin WardExec. Gen. Mang. of Selleys Global & ParchemKey Competitors1356444 (TOX.AX)ASX:TOX1884 (WOR.L)LON:WOR2020 BulkersOTC:TTBKF266353 (FENR.L)LON:FENR3 Sixty Risk SolutionsOTCMKTS:PTVYFView All Competitors DLX Stock Analysis - Frequently Asked Questions How were DuluxGroup's earnings last quarter? DuluxGroup Limited (ASX:DLX) posted its earnings results on Tuesday, November, 13th. The company reported $0.39 EPS for the quarter, topping the consensus estimate of $0.38 by $0.01. Is DuluxGroup a good dividend stock? DuluxGroup (ASX:DLX) pays an annual dividend of A$0.30 per share and currently has a dividend yield of 3.21%. Read our dividend analysis for DLX. What other stocks do shareholders of DuluxGroup own? Based on aggregate information from My MarketBeat watchlists, some companies that other DuluxGroup investors own include Whitehaven Coal (WHC), Global X Morningstar Global Technology ETF (TECH), Southcross Energy Partners (SXE), Orica (ORI), Jarden (JAH) and Growthpoint Properties Australia (GOZ). This page (ASX:DLX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DuluxGroup Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.